Priscilla N. Kelly
Science/AAAS, Washington DC,
BS, University of Western Australia, Molecular Genetics and Microbiology
PhD, University of Melbourne, immunology
Dr. Priscilla Kelly is a Senior Editor at Science, where she is responsible for the publication of biomedical research in areas that include COVID-19, cancer immunotherapy, gene/cell therapy, translational immunology and clinical trials. She earned her Bachelors of Science degree in Molecular Genetics and Microbiology from the University of Western Australia, where she worked with Nobel Laureate Professor Barry Marshall to develop vaccine candidates against the gastric bacterium Helicobacter pylori. She later obtained her PhD in Immunology from the University of Melbourne, where she specialized in the molecular mechanisms underlying immune cell cancers and was part of the international team that developed cancer drugs targeting the Bcl-2 protein family. She was later recruited to the US National Institutes of Health and the National Cancer Institute, to work on a number of drug development projects and clinical trials for treatment of blood cancers and autoimmune disorders. Dr. Kelly has overseen many exciting biomedical papers for Science, including recent COVID-19 vaccine and clinical trials. She is based in the Washington D.C area of the USA.